| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |